Search clinical trials for: fluticasone propionate/salmeterol in a multi-dose dry powder inhaler

Total 496185 results

Pharmaxis

Completed

Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years

Cystic Fibrosis

United Kingdom
AZTherapies, Inc.
Pharma Consulting Group AB; KCAS; Panax Clinical Research

Completed

Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers

Healthy Volunteers

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

United States
University Hospital, Antwerp
Chiesi Farmaceutici S.p.A.

Completed

Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients

Asthma

Belgium
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

Asthma

United States
Elpen Pharmaceutical Co. Inc.

Completed

BALLOON (Corticosteroid/laBA inhaLers in adoLescents' Asthma: Assessment Of Patients satisfactiON) Study (BALLOON)

Asthma

Greece
Chiesi Farmaceutici S.p.A.

Completed

Study to Investigate the Pharmacokinetics of CHF 6001 DPI Administered Via Nexthaler® Device or the Capsule for Oral Inhalation Via Aerolizer® Device

COPD

Belgium
GlaxoSmithKline

Completed

Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison

Pulmonary Disease, Chronic Obstructive

Belgium
Research in Real-Life Ltd
Orion Corporation, Orion Pharma

Completed

Real Life Effectiveness of Easyhaler (Orion)

Asthma
Massachusetts General Hospital

Completed

Vitamin D Deficiency in Adolescent Girls

Healthy | Vitamin D Deficiency

United States
Winthrop University Hospital
National Kidney Foundation

Completed

A Study of Oral Ergocalciferol to Treat Pruritis in Hemodialysis Patients (CRN11)

Pruritis

United States
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (REFLI)

Asthma

Germany
Guy Steuer
Schneider Children's Medical Center, Israel; Inspiromedical Inc

Unknown

Safety and Efficacy of the Inspiromatic Inhaler in Comparison to the Aerolizer Inhaler When Delivering Formoterol

Asthma

Israel
AstraZeneca

Completed

Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Turkey
Mayo Clinic
Jos University Teaching Hospital

Completed

Vitamin D and Genetics in Nutritional Rickets

Nutritional Rickets

Nigeria
University of Florida
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Dose-response of Inhaled Formoterol Using Methacholine Challenge as a Bioassay

Asthma

United States
Novartis

Completed

Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)

Lung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | COPD

Belgium
Novartis Pharmaceuticals

Completed

Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon Devices

Asthma

Germany, Netherlands, United Kingdom
NovaMed Pharmaceuticals Inc.

Unknown

Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

Asthma

China
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (Reco-Pilot)

Asthma

Finland
Barts & The London NHS Trust

Completed

Vitamin D, Chronic Kidney Disease (CKD) and the Microcirculation

Vitamin D Deficiency | Chronic Kidney Disease

United Kingdom
Pfizer

Completed

A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood After Dosing With Oral Inhalation From Dry Powder Inhalers

Pharmacokinetics

Singapore
MicroDose Defense Products L.L.C.
University of Pittsburgh; U.S. Army Space and Missile Defense Command

Completed

A Study of Inhaled Atropine Sulfate in Healthy Adults

Organophosphorus Poisoning

United States
Orion Corporation, Orion Pharma

Completed

Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers (PIFECO)

Pulmonary Disease, Chronic Obstructive | Asthma

United Kingdom, Finland
Pfizer

Completed

Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction

Pulmonary Disease, Chronic Obstructive | Asthma

Germany
Pfizer

Completed

Study To Estimate The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers

Healthy

Singapore
Pharmaxis

Completed

A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis

Cystic Fibrosis

Australia, New Zealand
Pfizer

Completed

A Study Estimating The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers

Healthy

Singapore
Pharmaxis

Completed

A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device

Healthy | Bronchiectasis

Australia
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhaler

Healthy

Finland
Pfizer

Completed

A Study to Estimate the Time Course of PF-00241939 Concentration in the Blood Following Dosing by Oral Inhalation From Dry Powder Inhalers (B0871003)

Pharmacokinetics

Singapore
Pfizer

Completed

A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers. (B0871002)

Healthy

Singapore
AstraZeneca

Completed

Atlantis Symbicort

Asthma
PharmAthene UK Limited
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed

Bacillus Anthracis (Anthrax)

United States
Pharmaxis

Completed

Inspiratory Flow and Volumes in Bronchiectatics

Bronchiectasis

Australia
Diamyd Therapeutics AB

Completed

Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes

Type 1 Diabetes

Sweden
University of Alberta
Novartis

Completed

The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction

Refractory Ascites | Type 2 Hepatorenal Syndrome

Canada
University Hospital Muenster
Novartis

Completed

Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome

Primary Sjogren's Syndrome

Germany
QDose Limited

Unknown

Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler

Diabetes Mellitus

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects

Chronic Obstructive Pulmonary Disease

China
National University of Malaysia

Not yet recruiting

Efficacy & Safety of Dry Powder Ivy Extract (Syrup Prospan) Versus NAC Among COPD Patients (SyProNAC)

Chronic Obstructive Pulmonary Disease

Malaysia
Fundació Eurecat
Centre de Diagnosi per la Imatge; Instituto de Investigación Biomédica de Girona... and other collaborators

Not yet recruiting

Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity (FATHIS+)

Visceral Obesity | Non-alcoholic Fatty Liver | Postmenopausal

Spain
GlaxoSmithKline

Recruiting

Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma

Asthma

United States, Canada, Argentina, Australia, Japan, Korea, Republic of, Taiwan
Liquidia Technologies, Inc.

Recruiting

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH (ASCENT)

Pulmonary Hypertension | Interstitial Lung Disease

United States
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Study to Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

China
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Recruiting

Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers

Bioequivalence

Greece
Lung Therapeutics, Inc

Recruiting

A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients

Idiopathic Pulmonary Fibrosis

United States, United Kingdom, Germany
University of North Carolina, Chapel Hill
Chiesi USA, Inc.

Recruiting

Inhaled Mannitol on Mucociliary Clearance in Moderate to Severe Cystic Fibrosis

Cystic Fibrosis

United States

3

Subscribe